Building on biotechnology: From vaccines to economic growth for Europe
EuropaBio National Associations Council Summit 2021 – Portugal
EuropaBio’s National Associations Council (NAC) is a platform that brings together all EuropaBio’s National Associations and helps to ensure coordination of EuropaBio actions throughout Europe. The NAC represents biotechnology priorities across Europe’s Member and partner countries, working together to build long term economic and societal benefit from biotechnology across sectors.
In 2021, the NAC is proud to host its first Summit focussed on priorities for commercial biotechnology development, delivering the Industrial Strategy within national and European ecosystems.
The NAC summit on May 10 will address how we learn from the COVID-19 response, to enable full societal and economic benefit from biotechnology in the future across sectors. Rapid technology development pathways, including partnering, investment and approvals, created in response to the pandemic have created new, faster routes to market. Although this was a unique scale and speed for vaccine development, it shows that biotech can perform quickly and strongly to address unmet issues in healthcare and sustainable development, creating a solution and also supporting economic recovery across Europe.
The EuropaBio NAC Summit is held during the Portuguese Presidency of the Council of EU and organized in collaboration with P-BIO. The outcomes from the Summit will include a EuropaBio NAC Position on building economic pathways from biotech post-Covid with the role of aligned and ambitious national policies and actions.
15:00 – Welcome: Claire Skentelbery, Director General of EuropaBio
15:15 – Session 1: Innovation and delivery for vaccine across countries and value chains
SMEs, large companies and universities active in vaccine development will present how they were able to bring the vaccines to patient in unprecedented speed. They will share the enabling factors behind their collaboration and development, including partnering, finance, policy and regulation, preparing for session 2 discussion and conclusions.
16:40 – Session 2: Vaccine learning – Driving economic delivery with biotechnology
A short SME session highlights the potential for economic growth from covid response pathways in Europe, before a panel discussion to establish how the precedents and learning from vaccine development can deliver Europe’s economic recovery across sectors and deliver policy priorities including the Green Deal.
Who should attend?
The EuropaBio NAC Summit is open and free of charge. You should attend if you are active within the development of biotechnology ecosystems at national or European levels, either as a technology stakeholder (academic or industrial) or a facilitator of technology maturation to market and patients (associations, tech transfer, investors, policy makers…). The event will have a strong discussion element and all participants can be actively involved. The event will also develop preparatory statements for delegate feedback plus post-event discussion on the planned NAC Position.